This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Skip to main content
null
JHEOR
  • Menu
  • Articles
    • Author Correction
    • Autoimmune Diseases
    • Brief Report
    • Cardiovascular Conditions
    • Commentary
    • Correspondence
    • Dermatological Diseases
    • Endocrinology
    • Gastrointestinal Conditions
    • General Indications
    • Genetic Disorders
    • Hematology
    • Infectious Diseases
    • Methodology and Healthcare Policy
    • Musculoskeletal Conditions
    • Nephrologic/Hepatologic Conditions
    • Neurological Disorders
    • Oncology
    • Ophthalmology
    • Other Conditions
    • Perspective
    • Psychological Conditions
    • Respiratory Diseases
    • Trauma Induced Conditions
    • Urological/Gynecological Diseases
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • Journal Policies
  • For Reviewers
  • search
  • X (formerly Twitter) (opens in a new tab)
  • Bluesky (opens in a new tab)
  • LinkedIn (opens in a new tab)
  • RSS feed (opens a modal with a link to feed)

RSS Feed

Enter the URL below into your favorite RSS reader.

http://localhost:42540/feed
ISSN 2327-2236
Neurological Disorders
Vol. 1, Issue 1, 2013May 24, 2013 EDT

The Impact of Medicaid Preferred Drug Lists on Utilization and Costs of Antipsychotic Medication

Christian Frois, Thomas O’Connell, Jacqueline Pesa, John Fastenau,
prior authorizationaccessformularypreferred drug list (pdl)medicaidschizophreniaantipsychotic
Copyright Logoccby-4.0 • https://doi.org/10.36469/9853
Photo by freestocks.org on Unsplash

Articles in Vol. 1, Issue 1, 2013

Vol. 1, Issue 1, 2013
  • Explaining Obesity- and Smoking-related Healthcare Costs through Unconditional Quantile Regression
    Bijan BorahJames NaessensKerry OlsenNilay Shah
  • Economic and Clinical Impact of Stroke and Warfarin Use for Patients with Non-valvular Atrial Fibrillation
    Li WangElyse FritschelOnur Baser
  • Economic Evaluation of Boceprevir for the Treatment of Patients with Genotype 1 Chronic Hepatitis C Virus Infection in Hungary
    Raymond OdhiamboJagpreet ChhatwalShannon Allen FerranteAntoine El KhouryElamin Elbasha
  • Generalized Propensity Score Matching with Multilevel Treatment Options
    Onur Baser
  • Applied Comparison of Meta-analysis Techniques
    Li WangColin Lewis-BeckElyse FritschelErdem BaserOnur Baser
  • The Impact of Medicaid Preferred Drug Lists on Utilization and Costs of Antipsychotic Medication
    Christian FroisThomas O’ConnellJacqueline PesaJohn Fastenau
JHEOR
1.
Frois C, O’Connell T, Pesa J, Fastenau J. The Impact of Medicaid Preferred Drug Lists on Utilization and Costs of Antipsychotic Medication. JHEOR. 2013;1(1):54-61. doi:10.36469/9853
Save article as...▾

View more stats

Powered by Scholastica, the modern academic journal management system